Inhibikase Therapeutics, Inc.
IKT
Nasdaq
Manufacturing
Chemicals
1,70 €
▲
0,01 €
(0,59%)
Cap. Boursière: 223,80 M
Prix
1,70 €
Cap. Boursière
223,80 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Historique des Prix
Tendances Financières
Objectif de Cours des Analystes
8 analystes
Buy
Actuel
1,70 €
Objectif
5,75 €
3,00 €
5,50 €
8,00 €
Prévisions
P/E Prévisionnel
-4,47
BPA Prévisionnel
-0,38 €
CA Est.
333 330,0
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
-0,38 €
-0,38 € – -0,38 €
|
333 330,0 | 1 |
| FY2026 |
-0,37 €
-0,37 € – -0,37 €
|
333 330,0 | 1 |
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| 2026 Q2 |
-0,09 €
-0,09 € – -0,09 €
|
0,0 | 1 |
| 2026 Q1 |
-0,09 €
-0,09 € – -0,09 €
|
0,0 | 1 |
Surprises de Résultats
Derniers 4 trimestres
| Trimestre | BPA Est. | BPA Réel | Surprise |
|---|---|---|---|
| Q42025 | -0,12 € | -0,09 € | +23,9% |
| Q32025 | -0,13 € | -0,13 € | 0,0% |
| Q22025 | -0,08 € | -0,11 € | -37,5% |
| Q12025 | -0,10 € | -0,15 € | -57,9% |
No fundamental snapshot available yet.
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2023 | FY2024 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 260 501,0 | 0,0 | 123 440,0 | 3,10 M |
| Net Income | -48,26 M | -19,03 M | -27,52 M | -18,05 M | -14,79 M |
| EPS (Diluted) | -0,49 | -3,57 | -1,16 | -0,72 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -51,97 M | -20,09 M | -28,59 M | -18,13 M | -14,77 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 29,79 M | 13,62 M | 17,21 M | 12,03 M | 11,36 M |
| SG&A Expenses | 23,56 M | 6,73 M | 11,38 M | 6,22 M | 6,51 M |
| D&A | — | — | — | — | — |
| Interest Expense | 3,72 M | 1,06 M | 1,07 M | 74 453,0 | 19 923,0 |
| Income Tax | 0,0 | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2023 | FY2024 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 181,20 M | 14,51 M | 98,60 M | 24,94 M | 42,47 M |
| Total Liabilities | 8,30 M | 3,53 M | 3,73 M | 3,90 M | 4,05 M |
| Shareholders' Equity | 172,90 M | 10,98 M | 94,87 M | 21,04 M | 38,42 M |
| Total Debt | — | 381 784,0 | — | — | 248 911,0 |
| Cash & Equivalents | 178,80 M | 9,17 M | 56,50 M | 7,19 M | — |
| Current Assets | 180,11 M | 14,21 M | 98,45 M | 24,37 M | — |
| Current Liabilities | 8,30 M | 3,44 M | 3,73 M | 3,70 M | 4,05 M |
{"event":"ticker_viewed","properties":{"ticker":"IKT","listing_kind":"stock","pathname":"/stocks/ikt","exchange":"Nasdaq","country":"US"}}